etoposide has been researched along with Autoimmune Lymphoproliferative Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lansigan, F; LeBlanc, RE | 1 |
1 other study(ies) available for etoposide and Autoimmune Lymphoproliferative Syndrome
| Article | Year |
|---|---|
Unraveling subcutaneous panniculitis-like T-cell lymphoma: An association between subcutaneous panniculitis-like T-cell lymphoma, autoimmune lymphoproliferative syndrome, and familial hemophagocytic lymphohistiocytosis.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Autoimmune Lymphoproliferative Syndrome; Biopsy; Bone Marrow; Bone Marrow Transplantation; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Dexamethasone; Etoposide; Female; Hepatitis A Virus Cellular Receptor 2; Humans; Lymphadenopathy; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell; Munc18 Proteins; Mutation; Panniculitis; Transplantation, Homologous; Treatment Outcome | 2021 |